Cargando…

A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals

OBJECTIVE: To describe an exploratory project to develop and pilot a novel patient educational tool that explains the concept of pharmacogenomics and its impact on warfarin dosing that can be utilized by health professionals providing patient counseling. METHODS: A pharmacogenomics educational tool...

Descripción completa

Detalles Bibliográficos
Autores principales: Barajas, Megan R., Formea, Christine M., McCormick, Jennifer B., Abdalrhim, Ahmed D., Han, Leona C., McBane, Robert D., Fiksdal, Alexander S., Kullo, Iftikhar J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339072/
https://www.ncbi.nlm.nih.gov/pubmed/25729462
http://dx.doi.org/10.1016/j.cptl.2014.11.019
_version_ 1782358834636914688
author Barajas, Megan R.
Formea, Christine M.
McCormick, Jennifer B.
Abdalrhim, Ahmed D.
Han, Leona C.
McBane, Robert D.
Fiksdal, Alexander S.
Kullo, Iftikhar J.
author_facet Barajas, Megan R.
Formea, Christine M.
McCormick, Jennifer B.
Abdalrhim, Ahmed D.
Han, Leona C.
McBane, Robert D.
Fiksdal, Alexander S.
Kullo, Iftikhar J.
author_sort Barajas, Megan R.
collection PubMed
description OBJECTIVE: To describe an exploratory project to develop and pilot a novel patient educational tool that explains the concept of pharmacogenomics and its impact on warfarin dosing that can be utilized by health professionals providing patient counseling. METHODS: A pharmacogenomics educational tool prototype was developed by an interdisciplinary team. During the pilot of the tool, focus group methodology was used to elicit input from patients based upon their perspectives and experiences with warfarin. Focus group sessions were audio-recorded and transcribed, and the data was analyzed through consensus coding in NVivo. RESULTS: The focus group participants were generally unfamiliar with the concept of pharmacogenomics but were receptive to the information. They thought the patient education tool was informative and would provide the most benefit to patients newly initiated on warfarin therapy. CONCLUSIONS: Preliminary results from this exploratory project suggest that implementation and further feasibility testing of this pharmacogenomics patient education tool should be performed in a population of newly initiated patients taking warfarin.
format Online
Article
Text
id pubmed-4339072
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-43390722016-03-01 A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals Barajas, Megan R. Formea, Christine M. McCormick, Jennifer B. Abdalrhim, Ahmed D. Han, Leona C. McBane, Robert D. Fiksdal, Alexander S. Kullo, Iftikhar J. Curr Pharm Teach Learn Article OBJECTIVE: To describe an exploratory project to develop and pilot a novel patient educational tool that explains the concept of pharmacogenomics and its impact on warfarin dosing that can be utilized by health professionals providing patient counseling. METHODS: A pharmacogenomics educational tool prototype was developed by an interdisciplinary team. During the pilot of the tool, focus group methodology was used to elicit input from patients based upon their perspectives and experiences with warfarin. Focus group sessions were audio-recorded and transcribed, and the data was analyzed through consensus coding in NVivo. RESULTS: The focus group participants were generally unfamiliar with the concept of pharmacogenomics but were receptive to the information. They thought the patient education tool was informative and would provide the most benefit to patients newly initiated on warfarin therapy. CONCLUSIONS: Preliminary results from this exploratory project suggest that implementation and further feasibility testing of this pharmacogenomics patient education tool should be performed in a population of newly initiated patients taking warfarin. 2015 /pmc/articles/PMC4339072/ /pubmed/25729462 http://dx.doi.org/10.1016/j.cptl.2014.11.019 Text en © 2014 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc/4.0/ This manuscript version is made available under the CC BY-NC-ND 4.0 license.
spellingShingle Article
Barajas, Megan R.
Formea, Christine M.
McCormick, Jennifer B.
Abdalrhim, Ahmed D.
Han, Leona C.
McBane, Robert D.
Fiksdal, Alexander S.
Kullo, Iftikhar J.
A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
title A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
title_full A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
title_fullStr A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
title_full_unstemmed A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
title_short A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
title_sort patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339072/
https://www.ncbi.nlm.nih.gov/pubmed/25729462
http://dx.doi.org/10.1016/j.cptl.2014.11.019
work_keys_str_mv AT barajasmeganr apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT formeachristinem apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT mccormickjenniferb apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT abdalrhimahmedd apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT hanleonac apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT mcbanerobertd apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT fiksdalalexanders apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT kulloiftikharj apatientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT barajasmeganr patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT formeachristinem patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT mccormickjenniferb patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT abdalrhimahmedd patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT hanleonac patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT mcbanerobertd patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT fiksdalalexanders patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals
AT kulloiftikharj patientcenteredapproachtothedevelopmentandpilotofawarfarinpharmacogenomicspatienteducationtoolforhealthprofessionals